Both in Pharmaceuticals
Anixa Biosciences vs Milestone Pharmaceuticals
Over the past year ANIX returned −16.4% and MIST returned −59.6%; their daily moves had a correlation of 0.32.
ANIX −16.4% MIST −59.6%Growth of $1, one year, split-adjusted
| Metric | ANIX | MIST |
|---|---|---|
| Price | $2.85 | $0.8200 |
| Market cap | $99.1M | $102.1M |
| Today | +2.15% | +3.09% |
| 1 month | −18.1% | −29.3% |
| 6 months | +14.0% | −18.8% |
| Year to date | −8.7% | −59.4% |
| 1 year | −16.2% | −59.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 94.3% |
| Net margin | — | −5118.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 43.6× |
| Net cash | $13.9M | $111.4M |
| Dividend yield | — | — |
| Volatility (60d) | 55.8% | 64.7% |
| Short % of float | 4.8% | 16.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).